Lexeo Therapeutics, Inc. Common Stock (LXEO) Earnings Per Share (EPS)
Lexeo Therapeutics, Inc. Common Stock (LXEO) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$32.60 |
| 2022-12-31 | -$36.36 |
| 2023-12-31 | -$12.40 |
| 2024-12-31 | -$3.09 |
| 2025-12-31 | -$1.86 |
How LXEO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| RLMD | Relmada Therapeutics Inc. | -$1.45 |
| XBIT | XBiotech Inc. | -$1.49 |
| VREX | Varex Imaging Corporation | -$1.70 |
| INO | Inovio Pharmaceuticals Inc. | -$1.81 |
| INMB | INmune Bio Inc. | -$1.86 |
These are five companies in the same sector as LXEO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Lexeo Therapeutics, Inc. Common Stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("LXEO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LXEO | $4.98 | +2.89% | 0.91M |
| 3 | ||||
| 4 | ||||
| 5 |